ACE2 and COVID-19: Hence, this may exacerbate the lower baseline ACE2 function in hypertensive patients, leading to the accumulation of AII and reduced angiotensin 1-7, and subsequently worse immune-related cytolysis and lung injury, which was validated by the linear association between elevated plasma AII levels and viral load or lung injury in COVID-19 patients [34].